52 results
8-K
EX-10.1
COYA
Coya Therapeutics Inc
20 May 24
Coya Therapeutics Announces $5 Million Strategic
5:00pm
with GAAP. Neither the Company nor any Subsidiary is in default with respect to any Indebtedness.
(cc) Tax Status. Except for matters that would … or filed all United States federal, state and local income and all foreign income and franchise tax returns, reports and declarations required by any
8-K
EX-99.1
9m143kj
19 Mar 24
Coya Therapeutics Provides a Corporate Update and Reports Fiscal 2023 Financial Results
8:21am
8-K
EX-10.1
i3280q u4lxfy5scroe3
6 Dec 23
Entry into a Material Definitive Agreement
7:30am
8-K
EX-4.1
ugzk19ifn9w7o8omzg8
6 Dec 23
Entry into a Material Definitive Agreement
7:30am
8-K
EX-10.1
qy0c giy2s5e
14 Jul 23
Departure of Directors or Certain Officers
5:01pm
8-K
EX-10.1
gl17dyby
10 Jul 23
Departure of Directors or Certain Officers
5:08pm
DEF 14A
0co6bxy7oe rt93zm
19 May 23
Definitive proxy
4:31pm
10-Q
safo7px8 y1e8
10 May 23
Quarterly report
7:14am
10-Q
EX-10.1
6j5wi6rfcomz8rr2hl
10 May 23
Quarterly report
7:14am
10-K
ct0pbfgqj6dep dera9a
29 Mar 23
Annual report
4:08pm
424B4
hc0j e7had1
30 Dec 22
Prospectus supplement with pricing info
4:17pm